The Food and Drug Administration today issued a final order exempting manufacturers from FDA premarket notification requirements for certain N95 respirators, disposable devices used to protect patients and health care providers from infection. Under a new memorandum of understanding between the FDA and National Institute for Occupational Safety and Health, organizations seeking to market N95 respirators that do not exceed certain criteria need only NIOSH certification. The final order and MOU, effective tomorrow, are intended to streamline regulatory requirements to help ensure adequate supply of the devices during public health emergencies.

Related News Articles

Headline
The AHA today submitted to the Food and Drug Administration legislative, regulatory and best practice recommendations to address new and chronic prescription…
Headline
A coalition of 40 health care and public health organizations, including the AHA, today urged the Senate to quickly pass the Pandemic and All-Hazards…
Headline
The House of Representatives last night passed legislation (H.R. 269) that includes the Pandemic and All-Hazards Preparedness and Advancing Innovation Act.
Headline
The Department of Health and Human Services’ Office of the Assistant Secretary of Preparedness and Response will host a Jan. 29 webinar on its new toolkit.
Headline
The House of Representatives Wednesday approved a legislative package (H.R. 7328) that includes the Pandemic and All-Hazards Preparedness and Advancing…
Headline
The Food and Drug Administration yesterday released revised draft guidance for facilities that compound human drugs as outsourcing facilities.